LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.05 | 770.25 | 9436 | 10413 | 0.9061 | 0.9482 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.05 | 770.25 | 10429 | 10413 | 1.0015 | 1.0008 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 72.27 | 770.25 | 9753 | 10730 | 0.9089 | 0.9503 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 72.27 | 770.25 | 10803 | 10730 | 1.0067 | 1.0035 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 74.50 | 770.25 | 10052 | 10991 | 0.9145 | 0.9539 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 74.50 | 770.25 | 11131 | 10991 | 1.0127 | 1.0066 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.75 | 770.25 | 10372 | 11262 | 0.9209 | 0.9579 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.75 | 770.25 | 11332 | 11262 | 1.0061 | 1.0032 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.98 | 770.25 | 10604 | 11518 | 0.9206 | 0.9581 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.98 | 770.25 | 11717 | 11518 | 1.0173 | 1.0088 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 81.20 | 770.25 | 10888 | 11766 | 0.9254 | 0.9609 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 81.20 | 770.25 | 12020 | 11766 | 1.0216 | 1.0109 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 83.42 | 770.25 | 11252 | 12031 | 0.9352 | 0.9665 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 83.42 | 770.25 | 12306 | 12031 | 1.0228 | 1.0114 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 85.64 | 770.25 | 11533 | 12287 | 0.9386 | 0.9685 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 85.64 | 770.25 | 12656 | 12287 | 1.0300 | 1.0149 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.86 | 770.25 | 11928 | 12543 | 0.9509 | 0.9752 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.86 | 770.25 | 12943 | 12543 | 1.0319 | 1.0156 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 3.21 | 770.25 | 986 | 904 | 1.0900 | 1.8992 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 3.21 | 770.25 | 970 | 904 | 1.0723 | 1.7018 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 5.44 | 770.25 | 1071 | 1012 | 1.0575 | 1.3043 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 5.44 | 770.25 | 1102 | 1012 | 1.0881 | 1.4769 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.66 | 770.25 | 1158 | 1090 | 1.0624 | 1.2568 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.66 | 770.25 | 1152 | 1090 | 1.0569 | 1.2335 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 10.06 | 770.25 | 1284 | 1218 | 1.0538 | 1.1647 | MN20160304_L02 | E06 |